Sirenas

Sirenas Marine Discovery's Vision: Computational Metabolomics for "Natural Product" Drug Discovery. Since 2012, Sirenas has been a pioneer and global leader in leveraging computational metabolomics to discover small molecule therapeutics from natural resources. Our approach, known as ATLANTIS™, applies cutting-edge computational algorithms to large proprietary metabolomics and bioassay datasets, enabling rapid discovery of key chemical and biological insights into small molecules present in complex samples from highly diverse biological environments.